Innovation
The COVID-19 crisis significantly accelerated advancements in testing technologies. In this sub-programme, research institutes and innovative startups collaborate on pioneering test innovations like CRISPR-Cas and LAMP, facilitating swift, adaptable, and precise DNA and RNA detection. Also, by integrating advanced optics and nanomaterials, we develop ultra-sensitive biosensors for the protein-based identification of pathogens.
P3Dx focuses on accelerating the applicability of test innovations with an emphasis on ease of use, accessibility and the right balance between speed and accuracy.